Two new candidates submitted for the Board of Directors

Controlant will hold its Annual General Meeting on 16 June 2023 at 14:00 GMT (16:00 CET). Two new candidates have submitted their eligibility for the Board of Directors ahead of the meeting; Søren Skou (as of 1 January 2024) and Steve Van Kuiken.

Published:

Sign up for the Controlant newsletter

Keep up with developments in pharma supply chain visibility. Sign up for Controlant Insights and receive our latest white paper.

Søren Skou is a globally recognized leader in shipping and logistics, who served as the CEO of A. P. Møller-Maersk from 2016 until 2022, and he has held various leadership positions within Maersk for the last 40 years. Skou is eligible as a Director to the Board as of 1 January 2024.

Steve Van Kuiken most recently served as a Senior Partner at McKinsey & Company. Over his long career at McKinsey, he founded and led the firm’s Healthcare Technology Practice as well as founding and building up McKinsey’s global technology practice, McKinsey Technology.

Other candidates for the Board of Directors are Asthildur Otharsdóttir, Chairman, Jørgen Rugholm, Kristin Fridgeirsdottir, Trausti Thormundsson—all currently serve as members of the Board.

More information will be published following the Annual General Meeting.

News

Controlant strengthens executive leadership and simplifies operating model to drive growth

Following the successful closing of a $35 million funding round, Controlant today announced changes to its executive leadership as well as a simplification of the operating model to improve execution power and reduce costs.

News

Controlant closes a $35 million funding round to advance market expansion and strategic product development

Controlant announces that it has successfully completed a $35 million financing round to seize opportunities in the ongoing digital transformation of pharma supply chains. The funding consists of $25 million in equity raised by new investors and current shareholders as well as a $10 million debt facility.

News

Controlant and SmartCAE to transform lane risk assessment and thermal packing selection in pharma

Controlant, a global leader in real-time supply chain monitoring, and SmartCAE, a pioneer in cold chain simulation, have announced a new partnership. The collaboration aims to transform thermal packaging solutions for the pharmaceutical industry and logistics service providers by combining Controlant’s expertise in pharma supply chains with SmartCAE’s powerful engine for thermal packaging simulation and lane risk assessment, to improve safety, efficiency, and sustainability.